Malcolm Sacco has recently been appointed Head of Research and Development at Medichem, a pharmaceutical company specialising in the development and manufacture of Active Pharmaceutical Ingredient (APIs) and Finished Dosage Forms (FDFs) for the global generics industry.
At the start of his career, Mr Sacco worked at Medichem for over seven years, beginning as a Quality Control Laboratory Analyst in 2011 and later serving as a Research and Development Officer. In 2018, he left Medichem to gain experience with Siegfried Holding AG and A2W Pharma.
In 2020, Mr Sacco rejoined Medichem as an FDF Industrialisation Manager.
In his new role, Mr Sacco will be managing technology transfer, overseeing development projects, and providing scientific guidance. He will also lead a team of scientists, manage laboratories, and evaluate manufacturing opportunities.
Featured Image:
Facebook and Linkedin / Malcolm Sacco
Chris Borg said that he will continue to build upon his experience, specialising in direct taxation and providing expert guidance.
Some companies are lucky to make history once. Ixaris has now done it twice — and counting. Here's why Ixaris ...
The Malta Digital Innovation Authority is working to provide more assistance by linking the difficulties faced by digital start-ups with ...
In the technologically-dependant world we live in, technology is a key asset necessary to sustain economic resilience, especially during such ...